These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 12716263

  • 1. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J.
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ, Fayed N, Pina MA.
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Apr; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 5. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U, Lais C, Rochmont Adu M, Kratzsch T, Frölich L, Maurer K, Zanella FE, Lanfermann H, Pantel J.
    Psychiatry Res; 2009 Jul 15; 173(1):1-7. PubMed ID: 19427767
    [Abstract] [Full Text] [Related]

  • 6. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.
    Kattapong VJ, Brooks WM, Wesley MH, Kodituwakku PW, Rosenberg GA.
    Arch Neurol; 1996 Jul 15; 53(7):678-80. PubMed ID: 8929176
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
    Mihara M, Hattori N, Abe K, Sakoda S, Sawada T.
    Neuroreport; 2006 Mar 20; 17(4):413-6. PubMed ID: 16514368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.
    Radiologia; 2006 Mar 20; 48(5):301-7. PubMed ID: 17168239
    [Abstract] [Full Text] [Related]

  • 10. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A, Rinaldi P, Tarducci R, Mariani E, Feliziani FT, Cherubini A, Pelliccioli GP, Gobbi G, Senin U, Mecocci P.
    Neurobiol Aging; 2006 Jul 20; 27(7):926-32. PubMed ID: 15936850
    [Abstract] [Full Text] [Related]

  • 11. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug 20; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study].
    Azevedo D, Bottino CM, Tatsch M, Hototian SR, Bazzarella MC, Castro CC.
    Arq Neuropsiquiatr; 2005 Dec 20; 63(4):1021-7. PubMed ID: 16400423
    [Abstract] [Full Text] [Related]

  • 14. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    Capizzano AA, Schuff N, Amend DL, Tanabe JL, Norman D, Maudsley AA, Jagust W, Chui HC, Fein G, Segal MR, Weiner MW.
    AJNR Am J Neuroradiol; 2000 Apr 20; 21(4):621-30. PubMed ID: 10782769
    [Abstract] [Full Text] [Related]

  • 15. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L, Blamire AM, Watson R, He J, Hayes L, O'Brien JT.
    Transl Psychiatry; 2016 Aug 30; 6(8):e877. PubMed ID: 27576166
    [Abstract] [Full Text] [Related]

  • 16. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A.
    J Am Geriatr Soc; 2002 Oct 30; 50(10):1707-10. PubMed ID: 12366626
    [Abstract] [Full Text] [Related]

  • 17. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC, Villar A, Molinuevo JL.
    Dement Geriatr Cogn Disord; 2007 Oct 30; 24(4):274-9. PubMed ID: 17717413
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D, Tatsch M, Hototian SR, Bazzarella MC, Castro CC, Bottino CM.
    Dement Geriatr Cogn Disord; 2008 Oct 30; 25(6):491-500. PubMed ID: 18441524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.